WH9-10524-65461
2 vaccinations
3 coded responses
25 check-ins
3 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 770 / TX
- Registered
- 2021-02-09
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-02-09
Registered in v-safe
-
2021-02-09
Dose 1 — Pfizer-BioNTech
- 2021-02-09
- 2021-02-10
- 2021-02-11
- 2021-02-12
- 2021-02-13
- 2021-02-14
- 2021-02-15
- 2021-02-16
- 2021-02-23
-
2021-03-02
Dose 2 — Pfizer-BioNTech
- 2021-03-02
- 2021-03-03
- 2021-03-04
- 2021-03-05
- 2021-03-06
- 2021-03-07
- 2021-03-08
- 2021-03-09
- 2021-03-16
- 2021-03-23
- 2021-03-30
- 2021-04-06
-
2021-04-13
Survey response — day 42, dose 2MedDRA: Headache, Vision blurred — Feeling: FairFree text: Blurry vision that last for 10-15 minutes; headache follows after vision resumes to normal. Occurs 2 to 3 times per week for the past two weeks.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-06-01
-
2021-09-02
Survey response — 6 months, dose 2MedDRA: Hypothyroidism — Feeling: Good · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: HypothyroidismMedDRA releases: 2021-09,2024-11 · check-in free text available
-
2021-09-02
Report sent to call center — 6 months, dose 2Get care from a doctor or other healthcare professional1 call case(s)
- 2021-09-24
-
2022-03-04
Survey response — 12 months, dose 2MedDRA: Pregnancy — Feeling: GoodFree text: PregnancyMedDRA releases: 2024-11 · check-in free text available
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-02-09 | Pfizer-BioNTech | |
| 2 | 2021-03-02 | Pfizer-BioNTech |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2021-09-02 | Unsuccessful |
Free text
Release 7 — day 42, dose 2
Symptoms: Blurry vision that last for 10-15 minutes; headache follows after vision resumes to normal. Occurs 2 to 3 times per week for the past two weeks.
Release 9 — 6 months, dose 2
Symptoms: Hypothyroidism
Release 11 — 12 months, dose 2
Symptoms: Pregnancy
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Headache | ✓ | ✓ | ✓ |
| SD | Hypothyroidism | ✓ | · | ✓ |
| SD | Pregnancy | · | · | ✓ |
| SD | Vision blurred | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release